TOKYO, Mar 30 (Pulse News Wire) – BML,INC. (4694.T) announced executive changes effective April 1, 2026.
Key appointments include: - Arashi Nobuki, currently Deputy President and Head of BML Inspection Department, will also take on roles as Chief Medical Genomic Business Unit Manager, Advanced Technology Development Division Director, Quality Assurance Room Director, and Comprehensive Research Institute Director. - Shibata Kenji, currently Senior Managing Director and Head of BML Inspection Department, will continue in those roles while adding responsibilities as Third General Research Laboratory Director and Reagent Department Director. - Yamashita Kazuhiro, currently Executive Officer responsible for Electronic Health Record Systems, will now oversee System Promotion Department. - Kakinuma Atushi, previously Chief Expert in Advanced Medical Development Department, will serve as Third General Research Laboratory Deputy Director.
- Yasasaki Toshi, previously Deputy Director of the Second General Research Laboratory, will now lead the Fourth General Research Laboratory. - Yokote Tomumu, previously Deputy Director of the System Promotion Department, will retain his role. - Yoshizawa Noru, previously Deputy Director of Healthcare Information Systems Sales Department, will now head the department. - Yuasa Miwa, previously Deputy Director of Electronic Health Records Systems, will remain in her position.
The changes aim to enhance operational efficiency and strategic direction within the company.
🟢 Confidence: High AI-translated content.